WilliamBErshlerMD
Hematology • Fairfax, VAMyeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Head, Division of Benign Hematolgy and Director ISCI Sickle Center, Inova Schar Cancer Institute, Fairfax, VA
Dr. Ershler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8501 Arlington Blvd
Ste 340
Fairfax, VA 22031Phone+1 703-207-0733Fax+1 571-472-1391
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1978 - 1980- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1974 - 1978
SUNY Upstate Medical UniversityClass of 1974
Certifications & Licensure
VA State Medical License 1996 - 2026
MD State Medical License 2004 - 2012
NY State Medical License 1998 - 2011
WI State Medical License 1975 - 2007
VT State Medical License 1980 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Idiopathic Anemia of Aging (IAA) Start of enrollment: 2004 Aug 01
- Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer Start of enrollment: 2004 Jul 01
- Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel Start of enrollment: 2004 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing.Sebastian R Mendez-Marti, Chad Zik, Sheinei Alan, Hongkun Wang, William B Ershler
Journal of Hematology. 2024-06-01 - 2 citationsA pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report.Cynthia W Tuthill, Ahmed Awad, Mary Parrigon, William B Ershler
International Immunopharmacology. 2023-04-01 - 4 citationsHemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease.William B Ershler, Laura M De Castro, Zahra Pakbaz, Zahra Pakbaz, Aaron Moynahan
Current Therapeutic Research, Clinical and Experimental. 2023-01-01
Press Mentions
- GBT Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting & ExpositionNovember 4th, 2020
Grant Support
- Chemokine Enhancement Of Radiation TherapyNational Institute On Aging2010
- Understanding LATE Life AnemiaNational Institute On Aging2009–2010
- Subject ASSESSMENT, Sample Procurement And Clinical OperationsNational Institute On Aging2009–2010
- Frailty Assessment And InterventionNational Institute On Aging2009–2010
- Delineating Early Events Osteoarthritis Of The KneeNational Institute On Aging2009
- Understanding LATE Life AnemiaNational Institute On Aging2008
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
